KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Total Current Liabilities (2016 - 2026)

Supernus Pharmaceuticals has reported Total Current Liabilities over the past 15 years, most recently at $338.2 million for Q4 2025.

  • Quarterly Total Current Liabilities rose 15.65% to $338.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $338.2 million through Dec 2025, up 15.65% year-over-year, with the annual reading at $338.2 million for FY2025, 15.65% up from the prior year.
  • Total Current Liabilities was $338.2 million for Q4 2025 at Supernus Pharmaceuticals, up from $330.6 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $735.5 million in Q2 2022 and troughed at $234.7 million in Q3 2021.
  • The 5-year median for Total Current Liabilities is $292.0 million (2024), against an average of $375.7 million.
  • Year-over-year, Total Current Liabilities skyrocketed 209.31% in 2022 and then plummeted 65.66% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $315.4 million in 2021, then skyrocketed by 118.14% to $688.0 million in 2022, then plummeted by 57.82% to $290.2 million in 2023, then increased by 0.76% to $292.4 million in 2024, then rose by 15.65% to $338.2 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Total Current Liabilities are $338.2 million (Q4 2025), $330.6 million (Q3 2025), and $286.4 million (Q2 2025).